However, the European Randomized Study of Screening for Prostate Cancer study group stated that planned PSA screening through structured population-based PSA screening may reduce PCa mortality after a 16-year follow-up [63,64]. This evidence concerns the gene KLK3 and posterior cortical atrophy.